DEF 14A

Company

REGENERON PHARMACEUTICALS, INC.

Filed

April 24, 2014

Period of Report

June 13, 2014

Accession Number

0001193125-14-157198

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →